(-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis related genes in non-alcoholic fatty liver disease.

Le Ying,Feng Yan,Yueling Zhao,Hugh Gao,Bryan Rg Williams,Yiqun Hu,Xiaofang Li,Run Tian,Ping Xu,Yuefei Wang

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY（2017）

引用 13|浏览19
暂无评分
关键词
atorvastatin,collagen,ECM,(-)-epigallocatechin-3-gallate,non-alcoholic fatty liver diseases
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要